By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kadmon Corporation (Formerly Known As Kadmon Pharmaceuticals) 

Alexandria Center for Life Sciences
450 East 29th Street, 5th Floor
New York  New York  10016  U.S.A.
Phone: 212-308-6000 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Kadmon To Present Additional Data Demonstrating Tesevatinib Safety For The Treatment Of Polycystic Kidney Disease At American Society of Nephrology Kidney Week 2016 11/21/2016 12:45:42 PM
Q3 Report Reveals Kadmon Has Quietly Reduced 15% of Workforce Since July 9/23/2016 10:11:51 AM
Kadmon Initiates Phase 2 Clinical Trial Evaluating KD025 In Chronic Graft-Versus Host Disease 9/22/2016 12:05:15 PM
Kadmon Initiates Placebo-Controlled Phase 2 Clinical Trial Evaluating KD025 In Psoriasis 9/22/2016 12:02:05 PM
Kadmon Reports Financial And Operational Results For The Three And Six Months Ended June 30, 2016 9/8/2016 10:55:56 AM
Kadmon To Present At Two Upcoming Investor Conferences 9/7/2016 11:12:58 AM
Kadmon Initiates Phase II Clinical Trial Evaluating Tesevatinib In Glioblastoma 8/29/2016 8:32:35 AM
Kadmon Announces Pricing Of Initial Public Offering 7/27/2016 10:31:23 AM
Why Investors are Still Throwing Cash at Debt-Ridden Kadmon, a NYC Biotech Founded By Ex-Con Sam Waksal 7/26/2016 6:59:29 AM
Kadmon Data Published In Science Signaling Show ROCK2 Signaling As A Key Modulator Of T Follicular Helper Cell Function In Autoimmune Diseases 7/20/2016 11:33:51 AM
123456
//-->